Board of Directors
Lars Gårdö, Non-Executive Chairman, is currently Chairman of the Karolinska Investment Fund, Swedfund International AB and Atle Industry AB. He was formerly chairman of 3i Nordic. His other directorships include Gadelius K.K, Pensionsgaranti and Carema Health & Care AB.
Alf Lindberg, Non-Executive Director, was formerly Executive Vice President of R&D at Aventis Pasteur and head of R&D at Wyeth Lederle Vaccines. He is a consultant to a number of biotechnology companies. Currently he is CEO of Noble Web AB, the official web site of the Nobel foundation. His other directorships include Catella Health Care Investments and Pharmexa A/S.
Eva-Lotta Allan, Non-Executive Director, is currently Chief Business Officer at Ablynx NV. Prior to joining Ablynx, she held senior business development and marketing roles at Vertex, Oxford Asymmetry and Oxford GlycoSciences. She has a degree in microscience from the University of Stockholm and a Masters certificate in marketing from the Institute for Higher Marketing Business School in Stockholm.
Ulf Tossman, Non-Executive Director, is currently Investment Director of InnovationsKapital. Previously he was at Carnegie Asset Management. Before joining the venture capital industry, he had different executive positions in global pharmaceutical companies, including Astra, Schering AG, and Fresenius Kabi. His other directorship includes Action Pharma, Ipsat, and Jolife.
Bengt Falk, CEO, See management team
Johan Rask, Deputy Director, is currently Investment Manager of InnovationsKapital. He is actively involved on the Boards and the development of a number of companies, including SantoSolve AS, Cellartis AB, Action Pharma AS and Ludesi AB. He holds a MSc in Industrial Engineering and Management from Chalmers University of Technology in Gothenburg.
Alf Lindberg, Non-Executive Director, was formerly Executive Vice President of R&D at Aventis Pasteur and head of R&D at Wyeth Lederle Vaccines. He is a consultant to a number of biotechnology companies. Currently he is CEO of Noble Web AB, the official web site of the Nobel foundation. His other directorships include Catella Health Care Investments and Pharmexa A/S.
Eva-Lotta Allan, Non-Executive Director, is currently Chief Business Officer at Ablynx NV. Prior to joining Ablynx, she held senior business development and marketing roles at Vertex, Oxford Asymmetry and Oxford GlycoSciences. She has a degree in microscience from the University of Stockholm and a Masters certificate in marketing from the Institute for Higher Marketing Business School in Stockholm.
Ulf Tossman, Non-Executive Director, is currently Investment Director of InnovationsKapital. Previously he was at Carnegie Asset Management. Before joining the venture capital industry, he had different executive positions in global pharmaceutical companies, including Astra, Schering AG, and Fresenius Kabi. His other directorship includes Action Pharma, Ipsat, and Jolife.
Bengt Falk, CEO, See management team
Johan Rask, Deputy Director, is currently Investment Manager of InnovationsKapital. He is actively involved on the Boards and the development of a number of companies, including SantoSolve AS, Cellartis AB, Action Pharma AS and Ludesi AB. He holds a MSc in Industrial Engineering and Management from Chalmers University of Technology in Gothenburg.